Details for New Drug Application (NDA): 008975
✉ Email this page to a colleague
NDA 008975 describes PURIFIED CORTROPHIN GEL, which is a drug marketed by Ani Pharms and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug. Additional details are available on the PURIFIED CORTROPHIN GEL profile page.
The generic ingredient in PURIFIED CORTROPHIN GEL is corticotropin. There are ten drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the corticotropin profile page.
The generic ingredient in PURIFIED CORTROPHIN GEL is corticotropin. There are ten drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the corticotropin profile page.
Summary for 008975
| Tradename: | PURIFIED CORTROPHIN GEL |
| Applicant: | Ani Pharms |
| Ingredient: | corticotropin |
| Patents: | 2 |
Suppliers and Packaging for NDA: 008975
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PURIFIED CORTROPHIN GEL | corticotropin | INJECTABLE;INJECTION | 008975 | NDA | Afton Scientific, LLC | 59227-860 | 59227-860-11 | 1 VIAL, MULTI-DOSE in 1 VIAL (59227-860-11) / 1 mL in 1 VIAL, MULTI-DOSE |
| PURIFIED CORTROPHIN GEL | corticotropin | INJECTABLE;INJECTION | 008975 | NDA | Afton Scientific, LLC | 59227-860 | 59227-860-15 | 1 VIAL, MULTI-DOSE in 1 VIAL (59227-860-15) / 5 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 40 UNITS/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
| Patent: | ⤷ Sign Up | Patent Expiration: | Oct 27, 2043 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS | ||||||||
| Patent: | ⤷ Sign Up | Patent Expiration: | Oct 27, 2043 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | ALLERGIC CONJUNCTIVITIS | ||||||||
| Patent: | ⤷ Sign Up | Patent Expiration: | Oct 27, 2043 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | ANTERIOR SEGMENT INFLAMMATION | ||||||||
Complete Access Available with Subscription
